Search website

If you cannot find, what you are looking for, try searching for it below or visit our FAQ-page.

Close

News & Events

Tillotts Pharma AG ist auf Expansionskurs

News

Tillotts Pharma AG ist auf Expansionskurs

View the full article here[...] Read more »
Marker-ion analysis for quantification of mucoadhesivity of microparticles in particle-retention assays

Scientific publications

Marker-ion analysis for quantification of mucoadhesivity of microparticles in particle-retention assays

D. Preisig, M. Weingartner, F. J. Varum, R. Bravo, R. Alles, J. Huwyler, M. Puchkov 20 [...] Read more »
Tillotts Pharma AG under Agreement to Acquire Global Rights for Entocort® (budesonide) from AstraZeneca Outside the U.S.

News

Tillotts Pharma AG under Agreement to Acquire Global Rights for Entocort® (budesonide) from AstraZeneca Outside the U.S.

PRESS RELEASE Tillotts is under agreement to expand and diversify the company’s por[...] Read more »
Tillotts Pharma and Numab Announce Exclusive Development and Licensing Agreement

Press Release

Tillotts Pharma and Numab Announce Exclusive Development and Licensing Agreement

PRESS RELEASE Agreement will focus on development of next-generation tumor necrosis f[...] Read more »
Tillotts Pharma supports the World IBD Day

News

Tillotts Pharma supports the World IBD Day

Press Release RHEINFELDEN, Switzerland, May 1, 2015 – The World IBD Day takes place a[...] Read more »
Many Europeans with mild-to-moderate ulcerative colitis nonadherent to therapy

News Press Release

Many Europeans with mild-to-moderate ulcerative colitis nonadherent to therapy

View the full article here[...] Read more »
1 14 15 16 17 18 22